Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
AI-curated news influencing MA price, sentiment, and trend
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
BOSTON, MA, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (Nasdaq: NCPL) (the “Company”) Today announced that it has received …
Figma crushed its Q2 revenue and earnings targets, yet the stock cratered nearly 15%. The culprit? Soaring AI costs that …
Indian cinema operators’ shares are rising after blockbuster openings for Hollywood movies Spider-Man: Brand New Day and The Odyssey.
MIDDLETON, MA, July 29, 2026 (GLOBE NEWSWIRE) -- SCWorx Corp. ("SCWorx" or the "Company"), a provider of data normalization and …
Giverny Capital Asset Management, LLC, an investment management company, recently published its second-quarter 2026 investor letter. A copy of the …
Multi-Provider AI Analysis